VRTX - VERTEX PHARMACEUTICALS INC COM
This page shows which of the focused investors we track hold VRTX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2012 it was held by 3 managers with an aggregate reported value of $54.44M, which is 0.01% of the combined portfolio.
As of Q3 2012, 3 tracked institutional managers held VRTX (VERTEX PHARMACEUTICALS INC COM) with an aggregate reported value of $54.44M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades VRTX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2012
- Ticker
- VRTX
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Daniel Loeb - Third Point | 0.77% | New | 700,000 | $39.12M |
| 2 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.69% | Reduce -50.0% | 223,786 | $12.51M |
| 3 | Torray Funds - Torray Funds | 0.62% | Add +14.0% | 50,268 | $2.81M |
Loading holder history for VRTX…